REN and hydrops fetalis: Multiple mechanistic studies alluded to the potential benefits of inhibition of the renin–angiotensin–aldosterone system with ARBs in HF,1, 2, 3 which were subsequently confirmed in large clinical trials, although this benefit varied depending on the population studied and the concomitant medication used.4, 5, 6, 7